Group 1 - The core point of the news is that Wanrun Co., Ltd. has seen a stock price increase of 6.25%, reaching 16.66 CNY per share, with a trading volume of 687 million CNY and a turnover rate of 4.68%, resulting in a total market capitalization of 15.377 billion CNY [1] - Wanrun Co., Ltd. is located in Yantai, Shandong Province, and was established on July 5, 1995. It was listed on December 20, 2011. The company operates in three main business areas: electronic information materials, environmental protection materials, and health products, with revenue contributions of 78.58% from functional materials, 20.09% from life sciences and pharmaceuticals, and 1.33% from other sources [1] Group 2 - According to data from the top ten heavy stocks of funds, one fund under the Fuguo Fund has a significant holding in Wanrun Co., Ltd. The Fuguo CSI 1000 Preferred Stock A (017038) held 18,800 shares in the third quarter, accounting for 0.75% of the fund's net value, ranking as the tenth largest heavy stock. The estimated floating profit today is approximately 18,400 CNY [2] - The Fuguo CSI 1000 Preferred Stock A (017038) was established on November 22, 2022, with a latest scale of 31.2779 million CNY. Year-to-date returns are 5.51%, ranking 2309 out of 5520 in its category; the one-year return is 50.72%, ranking 1469 out of 4203; and since inception, the return is 41.68% [2]

Core Viewpoint - Wanrun Co., Ltd. has seen a stock price increase of 5.74% on November 27, reaching 14.38 CNY per share, with a total market capitalization of 13.272 billion CNY, indicating a cumulative increase of 6.17% over three consecutive days [1] Group 1: Company Overview - Wanrun Co., Ltd. is located in Yantai, Shandong Province, and was established on July 5, 1995, with its listing date on December 20, 2011 [1] - The company operates in three main business areas: electronic information materials, environmental protection materials, and health products, with revenue contributions of 78.58% from functional materials, 20.09% from life sciences and pharmaceuticals, and 1.33% from other sources [1] Group 2: Shareholder Information - Among the top ten circulating shareholders of Wanrun Co., Ltd., one fund from GF Fund Management has entered the list, holding 10.8781 million shares, which is 1.2% of the circulating shares [2] - The fund, GF Multi-Factor Mixed Fund (002943), has generated a floating profit of approximately 8.4849 million CNY today and 8.5937 million CNY during the three-day increase [2] Group 3: Fund Performance - GF Multi-Factor Mixed Fund (002943) was established on December 30, 2016, with a current scale of 16.864 billion CNY and has achieved a year-to-date return of 29.52% [2] - The fund's one-year return stands at 30.98%, ranking 2478 out of 8054 in its category, while its cumulative return since inception is 420.05% [2] Group 4: Fund Manager Information - The fund managers of GF Multi-Factor Mixed Fund are Tang Xiaobin and Yang Dong, with Tang having a tenure of 10 years and 342 days, and Yang having a tenure of 4 years and 150 days [3] - Tang's best fund return during his tenure is 367.42%, while Yang's best return is 98.96% [3] Group 5: Additional Fund Information - Another fund, GF Smart Selection Start Mixed A (023761), holds 23,900 shares of Wanrun Co., Ltd., making it the second-largest holding in the fund, with a net asset ratio of 0.84% [4] - This fund was established on June 18, 2025, and has achieved a return of 19.88% since inception [5]

Core Viewpoint - Wanrun Co., Ltd. is a platform-based enterprise driven by R&D innovation, focusing on four main industries: electronic information materials, environmental materials, new energy materials, and life sciences and pharmaceuticals [2] Group 1: Company Overview - The company is engaged in the R&D, production, and sales of products across four key sectors [2] - Wanrun Co., Ltd. has developed production technologies for over 10,000 compounds, with more than 4,000 products already on the market [2]

Core Insights - Wanrun Co., Ltd. experienced a stock price increase of 0.96% on October 20, with a trading volume of 176 million yuan [1] - The company reported a financing buy-in of 16.41 million yuan and a financing repayment of 28.11 million yuan on the same day, resulting in a net financing outflow of 11.70 million yuan [1] - As of October 20, the total margin balance for Wanrun Co., Ltd. was 410 million yuan, which is 3.53% of its circulating market value, indicating a low financing balance compared to the past year [1] Financing and Margin Data - On October 20, the financing buy-in was 16.41 million yuan, while the current financing balance stands at 410 million yuan, which is below the 50th percentile level over the past year [1] - In terms of short selling, 300 shares were repaid and 1,500 shares were sold short on October 20, with a total short selling amount of 18,800 yuan [1] - The short selling balance is 7,000 shares, with a total value of 87,900 yuan, also indicating a low level compared to the past year [1] Company Overview - Wanrun Co., Ltd. is located in Yantai, Shandong Province, and was established on July 5, 1995, with its listing date on December 20, 2011 [1] - The company operates in three main business areas: electronic information materials, environmental protection materials, and health products, with revenue contributions of 78.58%, 20.09%, and 1.33% respectively [1] Financial Performance - As of June 30, the number of shareholders for Wanrun Co., Ltd. was 48,600, a decrease of 6.13% from the previous period, while the average circulating shares per person increased by 6.53% to 18,710 shares [2] - For the first half of 2025, the company reported a revenue of 1.87 billion yuan, a year-on-year decrease of 4.42%, while the net profit attributable to shareholders was 218 million yuan, reflecting a year-on-year increase of 1.35% [2] Dividend Distribution - Since its A-share listing, Wanrun Co., Ltd. has distributed a total of 2.005 billion yuan in dividends, with 646 million yuan distributed over the past three years [3] Institutional Holdings - As of June 30, 2025, Hong Kong Central Clearing Limited was the ninth largest circulating shareholder, holding 8.5757 million shares, an increase of 2.0926 million shares from the previous period [3]

Group 1 - The core viewpoint of the news is that Wanrun Co., Ltd. has seen a significant increase in its stock price, with a rise of 5.11% to 13.79 CNY per share, and a total market capitalization of 12.728 billion CNY [1] - Wanrun Co., Ltd. is engaged in three main business areas: electronic information materials, environmental protection materials, and health industry products, with functional materials accounting for 78.58% of revenue, life sciences and pharmaceuticals for 20.09%, and other categories for 1.33% [1] Group 2 - From the perspective of fund holdings, one fund under Galaxy Fund has a significant position in Wanrun Co., Ltd., specifically the Galaxy New Materials Stock Initiation A (020276), which reduced its holdings by 5,800 shares in the second quarter, maintaining 53,700 shares, representing 5.26% of the fund's net value [2] - The Galaxy New Materials Stock Initiation A (020276) has achieved a year-to-date return of 32.29%, ranking 1479 out of 4220 in its category, and a one-year return of 62.93%, ranking 1436 out of 3814 [2] - The fund manager of Galaxy New Materials Stock Initiation A is Jin Ye, who has been in the position for approximately 3 years and 265 days, with the fund's total asset size at 54.3398 million CNY [3]